These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35494967)

  • 21. Before and After: Attitude and Adverse Effects Induced by the First and Second Doses of mRNA BNT162b2 Vaccine among Healthcare Professionals in the First Weeks after Their Introduction in Poland.
    Pasternak G; Pieniawska-Śmiech K; Walkowiak M; Sado J; Pytel A; Jasińska P; Kierbiedź-Guzik N; Bolaczek P; Fleischer-Stępniewska K; Babicki M; Pentoś K; Lewandowicz-Uszyńska A
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37242987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study.
    Ripabelli G; Tamburro M; Buccieri N; Adesso C; Caggiano V; Cannizzaro F; Di Palma MA; Mantuano G; Montemitro VG; Natale A; Rodio L; Sammarco ML
    J Community Health; 2022 Apr; 47(2):211-225. PubMed ID: 34628568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Survey on the Side Effects of Pfizer/BioNTech COVID-19 Vaccine Among Vaccinated Adults in Saudi Arabia.
    Mohammed RA; Garout RM; Wahid S; Ayub F; Firas ZinAlddin LM; Sultan I
    Cureus; 2021 Nov; 13(11):e19222. PubMed ID: 34873547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous reporting of adverse reactions associated with the COVID-19 vaccine in health care professionals: A descriptive observational study conducted in a Portuguese hospital.
    Teófilo VSG; Pinho PRA; Cordeiro GJ; Saldanha NAF; Matos PMM; Ribeiro RAM; Moreira SM; Miller MSF; Dias ARM; Couto MFR; Norton PMPNS
    Porto Biomed J; 2023; 8(3):e219. PubMed ID: 37383526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    Hause AM; Gee J; Baggs J; Abara WE; Marquez P; Thompson D; Su JR; Licata C; Rosenblum HG; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1053-1058. PubMed ID: 34351881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
    Johnston MS; Galan A; Watsky KL; Little AJ
    JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
    Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
    [No Abstract]   [Full Text] [Related]  

  • 32. mRNA COVID-19 Vaccine Reactogenicity among Healthcare Workers: Results from an Active Survey in a Pediatric Hospital from Bucharest, January-February 2021.
    Crăciun MD; Nițescu GV; Golumbeanu M; Tănase AA; Pițigoi D; Săndulescu O; Crăciun P; Enciu BG; Bălănescu RN; Ulici A
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea.
    Kim S; Hwang I; Ko M; Kwon Y; Lee YK
    Osong Public Health Res Perspect; 2022 Jun; 13(3):230-237. PubMed ID: 35820672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals.
    Nittner-Marszalska M; Rosiek-Biegus M; Kopeć A; Pawłowicz R; Kosińska M; Łata A; Szenborn L
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34070671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate Analysis of Adverse Reactions and Recipient Profiles in COVID-19 Booster Vaccinations: A Prospective Cohort Study.
    Urakawa R; Isomura ET; Matsunaga K; Kubota K
    Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers.
    Kałucka S; Kusideł E; Głowacka A; Oczoś P; Grzegorczyk-Karolak I
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Immunoglobulin G Levels and Adverse Effects Following Vaccination with the BNT162b2 Vaccine among Japanese Healthcare Workers.
    Otani J; Ohta R; Sano C
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine.
    Green MS; Peer V; Magid A; Hagani N; Anis E; Nitzan D
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214694
    [No Abstract]   [Full Text] [Related]  

  • 40. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review.
    Dighriri IM; Alhusayni KM; Mobarki AY; Aljerary IS; Alqurashi KA; Aljuaid FA; Alamri KA; Mutwalli AA; Maashi NA; Aljohani AM; Alqarni AM; Alfaqih AE; Moazam SM; Almutairi MN; Almutairi AN
    Cureus; 2022 Mar; 14(3):e23526. PubMed ID: 35494952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.